Supplementary Figure S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients

<p>Supplementary Figure 2. PFS analysis in baseline population (C1D1) on TP53 mutations, by treatment arms.</p>

Guardado en:

Detalles Bibliográficos
Autor principal:	Javier Pascual (15018176) (author)
Otros Autores:	Miguel Gil-Gil (15052083) (author), Paula Proszek (17141889) (author), Christoph Zielinski (15054460) (author), Alistair Reay (17141892) (author), Manuel Ruiz-Borrego (15048425) (author), Rosalind Cutts (17141895) (author), Eva M. Ciruelos Gil (17141898) (author), Andrew Feber (15124144) (author), Montserrat Muñoz-Mateu (15054469) (author), Claire Swift (17141901) (author), Begoña Bermejo (15037896) (author), Jesus Herranz (15048443) (author), Mireia Margeli Vila (15054472) (author), Antonio Antón (15054475) (author), Zsuzsanna Kahan (17141904) (author), Tibor Csöszi (17141907) (author), Yuan Liu (15054484) (author), Daniel Fernandez-Garcia (17141910) (author), Isaac Garcia-Murillas (15018188) (author), Michael Hubank (15104113) (author), Nicholas C. Turner (17141913) (author), Miguel Martín (15011399) (author)
Publicado:	2025
Materias:	Cancer Cancer Detection and Diagnosis Therapeutic Research and Development Biomarkers Circulating tumor cells/DNA/exosomes Serum biomarkers Breast Cancer Translational Research
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares